Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
ENLIVEN THERAPEUTICS, INC. <ELVN.O>: JP MORGAN INITIATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $75

ENLIVEN THERAPEUTICS, INC. <ELVN.O>: JP MORGAN INITIATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $75

ReutersReuters2026/10/01 04:21
By:Reuters
ENLIVEN THERAPEUTICS, INC.
: JP MORGAN INITIATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $75
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!